Evidence map›Paper›PMID 35550663›Full record

ArticleCell host & microbe2022

Can maternal-child microbial seeding interventions improve the health of infants delivered by Cesarean section?

Suchitra K Hourigan, Maria Gloria Dominguez-Bello, Noel T Mueller

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03298334 (Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03298334 phase1 / phase2recruitingnot on this map

Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates: a Randomized Controlled Trial

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2018 to 2029Enrolled600ConditionsCesarean Delivery Affecting Newborn, Obesity, Childhood, Intestinal Microbiome, MicrobiotaArmsVaginal Seeding, No Vaginal Seeding
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Dysbiosis in the Pathogenesis of Atopic Dermatitis.The Journal of dermatology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Role of Skin Dysbiosis and Quorum Sensing in Atopic Dermatitis.JID innovations : skin science from molecules to population health · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Skin microbiome and dermatologic disorders.The Journal of clinical investigation · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Suchitra K HouriganClinical Microbiome Unit (CMU), Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: suchitra.hourigan@nih.gov.
Maria Gloria Dominguez-BelloDepartment of Biochemistry and Microbiology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08854, USA.
Noel T MuellerDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21218, USA.
Johns Hopkins University · USNational Institutes of Health · USRutgers, The State University of New Jersey · US

Funding

Vaginal microbiome seeding and health outcomes in Cesarean-delivered neonates: a randomized controlled trialZIAAI001361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOURIGAN, SUCHITRA · 2022 to 2025
$3.9M
A pilot study of fecal microbiota transplantation for Chronic Granulomatous Disorder Associated Colitis (CGD-AC)ZIAAI001357 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HOURIGAN, SUCHITRA · 2022 to 2025
$891k
Intramural NIH HHS ZIA AI001357
6 · The paper itself

Abstract

Maternal-child microbial seeding interventions expose Cesarean-section (C-section)-delivered infants to the maternal microbiome they bypass during Cesarean delivery. It is theorized such interventions restore the microbiome and normalize immune development to reduce the occurrence of C-section-associated inflammatory conditions. Here we discuss the rationale, evidence, and controversies surrounding such interventions.

Indexed as

Cesarean SectionMicrobiotaDelivery, ObstetricFemaleHumansInfantPregnancy

Identifiers

PMID35550663
PMCPMC9237654
OpenAlexW4280561780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.